[태그:] SecondaryFinding

Key Takeaways A patient with the same suspected hereditary cancer can have an actionable variant identified — or missed — depending on which country and which laboratory handles the case. Often what separates those outcomes is not the patient’s genome, but the composition of the panel applied to them. A study in the European Journal…